WallStreetZenWallStreetZen

NASDAQ: PDSB
Pds Biotechnology Corp Stock Forecast, Predictions & Price Target

Analyst price target for PDSB

Based on 2 analysts offering 12 month price targets for Pds Biotechnology Corp.
Min Forecast
$20.00+419.48%
Avg Forecast
$20.50+432.47%
Max Forecast
$21.00+445.45%

Should I buy or sell PDSB stock?

Based on 2 analysts offering ratings for Pds Biotechnology Corp.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PDSB stock forecasts and price targets.

PDSB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2023-11-15

1 of 1

Forecast return on equity

Is PDSB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is PDSB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PDSB revenue forecast

What is PDSB's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.1M
Avg 2 year Forecast
$12.2M
Avg 3 year Forecast
$56.4M

PDSB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PDSB$3.85$20.50+432.47%Buy
VIGL$3.20$18.50+478.13%Hold
MCRB$0.78$4.75+508.97%Hold
OTLK$9.37$51.63+451.00%Strong Buy
CLRB$3.64$20.00+450.21%Strong Buy

Pds Biotechnology Stock Forecast FAQ

Is Pds Biotechnology Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PDSB) stock is to Buy PDSB stock.

Out of 2 analysts, 0 (0%) are recommending PDSB as a Strong Buy, 2 (100%) are recommending PDSB as a Buy, 0 (0%) are recommending PDSB as a Hold, 0 (0%) are recommending PDSB as a Sell, and 0 (0%) are recommending PDSB as a Strong Sell.

If you're new to stock investing, here's how to buy Pds Biotechnology stock.

What is PDSB's revenue growth forecast for 2025-2027?

(NASDAQ: PDSB) Pds Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Pds Biotechnology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast PDSB's revenue for 2025 to be $34,218,539, with the lowest PDSB revenue forecast at $34,218,539, and the highest PDSB revenue forecast at $34,218,539. On average, 3 Wall Street analysts forecast PDSB's revenue for 2026 to be $378,737,015, with the lowest PDSB revenue forecast at $155,538,815, and the highest PDSB revenue forecast at $699,924,668.

In 2027, PDSB is forecast to generate $1,754,508,941 in revenue, with the lowest revenue forecast at $1,116,893,123 and the highest revenue forecast at $2,706,375,381.

What is PDSB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PDSB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PDSB's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PDSB price target, the average PDSB price target is $20.50, with the highest PDSB stock price forecast at $21.00 and the lowest PDSB stock price forecast at $20.00.

On average, Wall Street analysts predict that Pds Biotechnology's share price could reach $20.50 by Mar 27, 2025. The average Pds Biotechnology stock price prediction forecasts a potential upside of 432.47% from the current PDSB share price of $3.85.

What is PDSB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PDSB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.